ORAL HYGIENE, PERIODONTAL STATUS AND QUALITY OF LIFE

April 25, 2026 updated by: Zeynep AKGÜL, Abant Izzet Baysal University

EVALUATION OF THE EFFECT OF INDIVIDUALS' ORAL HYGIENE HABITS AND PERIODONTAL STATUS ON QUALITY OF LIFE

This cross-sectional study aims to evaluate the relationship between oral hygiene habits, periodontal status, and oral health-related quality of life in adult individuals. A total of approximately 160 participants attending the Department of Periodontology will be included. Periodontal status will be assessed using standard clinical parameters, including probing depth, clinical attachment loss, bleeding on probing, and plaque index. In addition, the Periodontal Inflamed Surface Area (PISA) will be calculated to quantify inflammatory burden. Oral health-related quality of life will be evaluated using the OSHIP-Perio questionnaire, a validated patient-reported outcome measure specific to periodontal conditions. The study will investigate the association between clinical periodontal findings, oral hygiene practices, and quality of life outcomes. The findings are expected to provide a comprehensive understanding of both clinical and patient-centered aspects of periodontal disease and contribute to improved individualized treatment approaches.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

160

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Turkey (Türkiye)
    • Bolu
      • Bolu, Bolu, Turkey (Türkiye), 14100
        • Recruiting
        • Faculty of Dentistry, Bolu Abant İzzet Baysal University, Department of Periodontics
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

The study population will consist of individuals aged 18 years and older presenting to the Department of Periodontology at Bolu Abant İzzet Baysal University Faculty of Dentistry. Participants will be classified into periodontally healthy, gingivitis, and periodontitis groups according to the 2017 classification of periodontal diseases and conditions.

Description

Inclusion Criteria:

  • Individuals aged 18 years and older
  • Patients presenting to the Department of Periodontology Individuals willing to participate and provide informed consent

Exclusion Criteria:

  • Use of antibiotics or anti-inflammatory drugs within the last 3 months
  • History of periodontal treatment within the last 6 months
  • Pregnancy or lactation
  • Individuals unable to complete the questionnaire

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
PERIODONTITIS PATIENTS

Patients with a diagnosis of periodontitis, irrespective of its stage and grade.This group will include individuals diagnosed with periodontitis, characterized by interdental clinical attachment loss (CAL) at ≥2 non-adjacent teeth and/or buccal/oral CAL ≥3 mm with pocketing >3 mm at ≥2 teeth, not attributable to non-periodontal causes.

Participants will present with increased probing pocket depths (PPD ≥4 mm), bleeding on probing (BOP), and radiographic evidence of alveolar bone loss. The diagnosis and staging of periodontitis will be established according to the criteria defined by the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions.
Other: Oral Health Assessment and OSHIP-Perio Questionnaire
Participants will undergo a comprehensive periodontal clinical examination, including assessment of probing pocket depth (PPD), clinical attachment loss (CAL), bleeding on probing (BOP), and plaque and gingival indices. In addition, participants will complete the OSHIP-Perio questionnaire to evaluate the impact of periodontal status on oral health-related quality of life. No invasive or therapeutic intervention will be performed as part of this study.
GINGIVITIS PATIENTS

This group will include individuals diagnosed with gingivitis, characterized by the presence of gingival inflammation without clinical attachment loss or radiographic evidence of alveolar bone loss.

Participants will exhibit bleeding on probing (BOP) ≥10%, with probing pocket depths (PPD) ≤3 mm at all sites. The diagnosis of gingivitis will be established according to the criteria defined by the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions.
Other: Oral Health Assessment and OSHIP-Perio Questionnaire
Participants will undergo a comprehensive periodontal clinical examination, including assessment of probing pocket depth (PPD), clinical attachment loss (CAL), bleeding on probing (BOP), and plaque and gingival indices. In addition, participants will complete the OSHIP-Perio questionnaire to evaluate the impact of periodontal status on oral health-related quality of life. No invasive or therapeutic intervention will be performed as part of this study.
periodontally healthy individuals

This group will consist of systemically healthy individuals presenting with clinically healthy periodontal tissues. Participants will have no clinical signs of gingival inflammation, no periodontal pocket formation, no clinical attachment loss (CAL), and no radiographic evidence of alveolar bone loss.

All individuals in this group will demonstrate probing pocket depths (PPD) ≤3 mm at all sites and bleeding on probing (BOP) <10%, in accordance with the criteria defined by the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions.
Other: Oral Health Assessment and OSHIP-Perio Questionnaire
Participants will undergo a comprehensive periodontal clinical examination, including assessment of probing pocket depth (PPD), clinical attachment loss (CAL), bleeding on probing (BOP), and plaque and gingival indices. In addition, participants will complete the OSHIP-Perio questionnaire to evaluate the impact of periodontal status on oral health-related quality of life. No invasive or therapeutic intervention will be performed as part of this study.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oral health-related quality of life (OSHIP-Perio score)
Time Frame: Baseline (single visit)
The primary outcome is the Oral and Systemic Health Impact Profile for Periodontal Disease (OSHIP-Perio) total score obtained from a 21-item questionnaire assessing the impact of periodontal status on oral health-related quality of life.
Baseline (single visit)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Probing Pocket Depth (PPD)
Time Frame: Baseline (single visit)
Probing pocket depth (PPD) will be measured in millimeters using a calibrated periodontal probe at six sites per tooth.
Baseline (single visit)
Periodontitis Stage (2017 Classification)
Time Frame: Baseline (single visit)
Periodontitis stage will be determined according to the 2017 World Workshop Classification of Periodontal Diseases, based on clinical attachment loss, radiographic bone loss, and tooth loss.
Baseline (single visit)
Clinical Attachment Level (CAL)
Time Frame: Baseline (single visit)
Clinical attachment level (CAL) will be measured in millimeters using a periodontal probe at six sites per tooth.
Baseline (single visit)
Bleeding on Probing (BOP)
Time Frame: Baseline (single visit)
Bleeding on probing (BOP) will be assessed as the presence or absence of bleeding within 15 seconds after probing and recorded as percentage (%).
Baseline (single visit)
Periodontitis Grade (2017 Classification)
Time Frame: Baseline (single visit)
Periodontitis grade will be determined according to the 2017 World Workshop Classification, based on rate of progression, risk factors, and clinical parameters.
Baseline (single visit)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Abant Izzet Baysal University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 15, 2025

Primary Completion (Estimated)

May 15, 2026

Study Completion (Estimated)

June 15, 2026

Study Registration Dates

First Submitted

April 9, 2026

First Submitted That Met QC Criteria

April 9, 2026

First Posted (Actual)

April 15, 2026

Study Record Updates

Last Update Posted (Actual)

April 30, 2026

Last Update Submitted That Met QC Criteria

April 25, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • BAIBU-SBF-RK-02

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data (IPD) will not be publicly shared to protect participant confidentiality. De-identified and aggregated data may be available from the corresponding author upon reasonable request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Periodontitis

Clinical Trials on Oral Health Assessment and OSHIP-Perio Questionnaire

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Montenegro

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe